These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Safety of high risk in vitro diagnostic medical devices : international and national measures]. Halbauer J; Siekmeier R; Funk M Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Jun; 52(6):610-8. PubMed ID: 19421725 [TBL] [Abstract][Full Text] [Related]
24. Pre-analytical processes in medical diagnostics: New regulatory requirements and standards. Dagher G; Becker KF; Bonin S; Foy C; Gelmini S; Kubista M; Kungl P; Oelmueller U; Parkes H; Pinzani P; Riegman P; Schröder U; Stumptner C; Turano P; Sjöback R; Wutte A; Zatloukal K N Biotechnol; 2019 Sep; 52():121-125. PubMed ID: 31102798 [TBL] [Abstract][Full Text] [Related]
25. Post market surveillance in the german medical device sector - current state and future perspectives. Zippel C; Bohnet-Joschko S Health Policy; 2017 Aug; 121(8):880-886. PubMed ID: 28697849 [TBL] [Abstract][Full Text] [Related]
26. The new EU regulation on in vitro diagnostics: potential issues at the interface of medicines and companion diagnostics. Enzmann H; Meyer R; Broich K Biomark Med; 2016 Dec; 10(12):1261-1268. PubMed ID: 27661101 [TBL] [Abstract][Full Text] [Related]
27. Has the introduction of the European Parliament Directive 98/79/EC from 1998-10-27--concerning in-vitro diagnostic devices (IVD-directive) influenced performance of hormone immunoassay kits in terms of precision and accuracy? Results from selected external quality assessment (EQA) schemes between 1993 and 2008. Wood WG Clin Lab; 2009; 55(3-4):86-105. PubMed ID: 19462931 [TBL] [Abstract][Full Text] [Related]
28. How does medical device regulation perform in the United States and the European union? A systematic review. Kramer DB; Xu S; Kesselheim AS PLoS Med; 2012; 9(7):e1001276. PubMed ID: 22912563 [TBL] [Abstract][Full Text] [Related]
29. The EU one-stop-shop collection of publicly available information on COVID-19 Petrillo M; Querci M; Tkachenko O; Siska IR; Ben E; Angers-Loustau A; Bogni A; Brunetto A; Fabbri M; Garlant L; Lievens A; Munoz A; Paracchini V; Pietretti D; Puertas-Gallardo A; Raffael B; Sarno E; Tregoat V; Zaro F; Van den Eede G F1000Res; 2020; 9():1296. PubMed ID: 33564397 [TBL] [Abstract][Full Text] [Related]
30. Companion Diagnostics: State of the Art and New Regulations. Valla V; Alzabin S; Koukoura A; Lewis A; Nielsen AA; Vassiliadis E Biomark Insights; 2021; 16():11772719211047763. PubMed ID: 34658618 [TBL] [Abstract][Full Text] [Related]
31. Legal regulation of the production and trade of medical devices and medical equipment in the EU and US: experience for Ukraine. Pashkov V; Kotvitska A; Harkusha A Wiad Lek; 2017; 70(3 pt 2):614-618. PubMed ID: 28713093 [TBL] [Abstract][Full Text] [Related]
32. [Difficulties in registration for export of traditional Chinese medicines to EU under directive 2004/24/EC and countermeasures]. Ni HX; Sun YY Zhongguo Zhong Yao Za Zhi; 2013 May; 38(9):1447-50. PubMed ID: 23944086 [TBL] [Abstract][Full Text] [Related]
33. Impact of the new European Union Hermans AMM; Maliepaard M; Boon WPC; Pasmooij AMG Expert Rev Mol Diagn; 2022 May; 22(5):583-590. PubMed ID: 35673983 [TBL] [Abstract][Full Text] [Related]
34. Introduction to in vitro diagnostic device regulatory requirements. Day J Methods Mol Biol; 2013; 949():103-12. PubMed ID: 23329438 [TBL] [Abstract][Full Text] [Related]
35. In vitro diagnostic medical device regulation (IVDR): the end of laboratory developed tests (LDT)? Barberis M Pathologica; 2021 Apr; 113(2):68-69. PubMed ID: 33955428 [No Abstract] [Full Text] [Related]
36. How the European in vitro diagnostic regulation could negatively impact the European response to the next pandemic: an urgent call for action before May 2022. Vermeersch P; André E Clin Microbiol Infect; 2021 Aug; 27(8):1074-1075. PubMed ID: 33979703 [No Abstract] [Full Text] [Related]
37. European regulation model for herbal medicine: The assessment of the EU monograph and the safety and efficacy evaluation in marketing authorization or registration in Member States. Qu L; Zou W; Wang Y; Wang M Phytomedicine; 2018 Mar; 42():219-225. PubMed ID: 29655689 [TBL] [Abstract][Full Text] [Related]
39. In vitro diagnostics for screening the blood supply: the new European regulation for IVD and the WHO IVD prequalification programme. Mbunkah HA; Reinhardt J; Kafere C; Scheiblauer H; Prat I; Nübling CM Vox Sang; 2021 Jan; 116(1):3-12. PubMed ID: 32986873 [TBL] [Abstract][Full Text] [Related]
40. [European Community procedure of marking for a reagent. Application to HIV 1 and 2 detection kits]. Bénichou-Debasc K; Gautheret-Dejean A Virologie (Montrouge); 2009 Jun; 13(3):171-179. PubMed ID: 36151670 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]